Medroxyprogesterone Injection (Subcutaneous) and Panitumumab
Determining the interaction of Medroxyprogesterone Injection (Subcutaneous) and Panitumumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: medroxyprogesterone
Brand name: Provera, Depo-Provera, Depo-subQ provera 104, Depo-Provera Contraceptive
Synonyms: Medroxyprogesterone, MedroxyPROGESTERone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Medroxyprogesterone Injection (Subcutaneous)-Panitumumab Intravenous
- Medroxyprogesterone Injection (Subcutaneous)-Panixine
- Medroxyprogesterone Injection (Subcutaneous)-Panixine DisperDose
- Medroxyprogesterone Injection (Subcutaneous)-Panlor
- Medroxyprogesterone Injection (Subcutaneous)-Panlor Tablet
- Medroxyprogesterone Injection (Subcutaneous)-Panlor Tablets
- Panitumumab-Medroxyprogesterone Injection ER
- Panitumumab-Medroxyprogesterone Intramuscular
- Panitumumab-Medroxyprogesterone Tablets
- Panitumumab-Medworx Patch
- Panitumumab-Mefenamic acid
- Panitumumab-Mefloquine